Live Breaking News & Updates on Richard siegel

Stay informed with the latest breaking news from Richard siegel on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Richard siegel and stay connected to the pulse of your community

Novartis Acquires IFM Due to Develop First-In-Class STING Antagonist Program Targeting Innate Immune System

IFM will be eligible for potential milestone payments in aggregate value of up to $835 million, giving Novartis full rights to its STING antagonist program

Massachusetts , United-states , Boston , H-martin-seidel , Richard-siegel , Gary-glick , Novartis , Atlas-venture , Interferon-genes ,

20 McClatchy Sites Delete False Story About NJ Synagogue 'Sale' of 'Palestinian Land'

20 McClatchy Sites Delete False Story About NJ Synagogue 'Sale' of 'Palestinian Land'
camera.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from camera.org Daily Mail and Mail on Sunday newspapers.

Israel , Washington , United-states , Englewood , California , New-jersey , United-kingdom , Sacramento , Idaho , Fresno , Modesto , West-bank

Calypso Enters into Agreement to Be Acquired by Novartis

Calypso is a European biotech translating Interleukin-15 biology into medical breakthroughs by developing CALY-002, an anti-IL-15 monoclonal antibody, for an array of autoimmune indicationsThe acquisition of Calypso gives Novartis full rights to CALY-002, a pipeline-in-a-drug with potential in dermatology, gastro-in...

Netherlands , Amsterdam , Noord-holland , Switzerland , Geneva , Genè , Richard-siegel , Alain-vicari , Bernard-coulie , Head-of-immunology-research-at-novartis , Lazard , Novartis